A 1989 biology graduate of the University of Richmond, she joined FDA in April 1991. She was on the job eight months before she accompanied MacLaughlin to the oxygen repacker. A few weeks after those inspections she started inspecting gas repackers by herself. She admits she was pretty nervous that first time on her own. MacLaughlin isn't smiling.
Further resistance can result in seizures, injunctions and prosecutions.
The priority for investigators is public safety, and since they are part of the public, their own safety is also at stake. If she finds problems, her goal is to avert disaster. Dori Stehlin is a staff writer for FDA Consumer. New Unit Fights Crime Tampering. Illegal sales of prescription drug samples.